Chebulic acid inhibits advanced glycation end products-mediated vascular dysfunction by suppressing ROS via the ERK/Nrf2 pathway

Chebulic acid inhibits advanced glycation end products-mediated vascular dysfunction by suppressing ROS via the ERK/Nrf2 pathway

Advanced glycation end-products (AGEs) considered as a fatal mediator in the diabetic atherosclerotic pathology. In this study, we evaluated the effects of chebulic acid (CA) on anti-oxidant activities and its glycoaldehyde-induced AGEs (glycol-AGEs)-mediates systemic vascular dysfunction in endothe...

Full description

Bibliographic Details
Main Authors:	Mi-Hyun Nam, Won-rak Son, Sung-Yong Yang, Young-Seok Lee, Kwang-Won Lee
Format:	Article
Language:	English
Published:	Elsevier 2017-09-01
Series:	Journal of Functional Foods
Subjects:	Advanced glycation end products Oxidative stress Nuclear factor E2-related factor Inflammation Vascular dysfunction
Online Access:	http://www.sciencedirect.com/science/article/pii/S1756464617303754

Similar Items

Glycolaldehyde, an Advanced Glycation End Products Precursor, Induces Apoptosis via ROS-Mediated Mitochondrial Dysfunction in Renal Mesangial Cells
by: Cha, Y.-S, et al.
Published: (2022)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01)

Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?
by: Deepika Garg, et al.
Published: (2015-12-01)

Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)

Spironolactone ameliorates endothelial dysfunction through inhibition of the AGE/RAGE axis in a chronic renal failure rat model
by: Chun-Cheng Wang, et al.
Published: (2019-09-01)

Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy
by: Jing Xu, et al.
Published: (2018-07-01)

Phloroglucinol prevents albumin glycation as well as diminishes ROS production, glycooxidative damage, nitrosative stress and inflammation in hepatocytes treated with high glucose
by: Krzysztof Drygalski, et al.
Published: (2021-10-01)

The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts
by: Monika Czech, et al.
Published: (2021-05-01)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
by: Anastasia Papagrigoraki, et al.
Published: (2017-11-01)

Advanced Glycation End-Products and Their Receptor-Mediated Roles: Inflammation and Oxidative Stress
by: Parisa Younessi, et al.
Published: (2011-09-01)

Systemic lupus erythematosus and glycation proces
by: Agnieszka Nowak, et al.
Published: (2020-04-01)

Inhibiting Receptor of Advanced Glycation End Products Attenuates Pressure Overload-Induced Cardiac Dysfunction by Preventing Excessive Autophagy
by: Wenbin Gao, et al.
Published: (2018-09-01)

Antioxidant and anti-advanced glycation end products formation properties of palmatine
by: Sharma Mridula, et al.
Published: (2021-05-01)

The Protective Effect of Brazilian Propolis against Glycation Stress in Mouse Skeletal Muscle
by: Tatsuro Egawa, et al.
Published: (2019-09-01)

Eucommia ulmoides Ameliorates Glucotoxicity by Suppressing Advanced Glycation End-Products in Diabetic Mice Kidney
by: Moon Ho Do, et al.
Published: (2018-02-01)

A Study on Urinary Glycated Albumin to urinary albumin excretion in gestational diabetes mellitus
by: Chandramallika Paul, et al.
Published: (2021-02-01)

Advanced Glycation End Product (AGE)-AGE Receptor (RAGE) System Upregulated Connexin43 Expression in Rat Cardiomyocytes via PKC and Erk MAPK Pathways
by: Shaoxiang Weng, et al.
Published: (2013-01-01)

Dietary Advanced Glycation End Products and Aging
by: Karen Chapman-Novakofski, et al.
Published: (2010-12-01)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
by: Takanobu Takata, et al.
Published: (2020-06-01)

Receptor of advanced glycation end products and cardiovascular risk in elderly with type 2 diabetes mellitus
by: Claudia Borsa, et al.
Published: (2018-02-01)

Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats
by: Xiaobin Tan, et al.
Published: (2015-04-01)

Acetoacetate enhancement of glucose mediated DNA glycation
by: M. Bagherzadeh-Yazdi, et al.
Published: (2021-03-01)

Cinnamic Acid and Its Derivatives Inhibit Fructose-Mediated Protein Glycation
by: Sirintorn Yibchok-anun, et al.
Published: (2012-02-01)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
by: Adel M. A. Assiri, et al.
Published: (2018-05-01)

Antiglycation potential of commercial available extracts of two Indian medicinal plants: Pterocarpus marsupium and Artocarpus lakoocha using advanced glycation end products (AGE) competitive fluorescence assay
by: Alpana Pande, et al.
Published: (2021-01-01)

A novel crosslinked type of advanced glycation end-product derived from lactaldehyde
by: Tomoaki Shigeta, et al.
Published: (2020-11-01)

Gamma-linolenic acid ameliorated glycation-induced memory impairment in rats
by: Shahab Ali Khan, et al.
Published: (2017-01-01)

Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
by: Hiroyasu Mori, et al.
Published: (2019-09-01)

Association of advanced glycation end products in Dupuytren disease
by: Fumiaki Takase, et al.
Published: (2018-06-01)

High-fat diet-induced kidney alterations in rats with metabolic syndrome: endothelial dysfunction and decreased antioxidant defense
by: Rangel Silvares R, et al.
Published: (2019-09-01)

Glyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Oxidative Damage and Inflammatory Response by Interacting with RAGE
by: Hee-Weon Lee, et al.
Published: (2021-09-01)

Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells
by: Xiaomei Ren, et al.
Published: (2017-04-01)

Serum Levels of Antibodies to Advanced Glycation End Products in Patients with Type 2 Diabetes Mellitus and Hypertension
by: Asparuh Nikolov, et al.
Published: (2020-06-01)

The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway
by: Liuyang Ren, et al.
Published: (2021-01-01)

Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality
by: Cheng YZ, et al.
Published: (2014-11-01)

Evaluation of in vitro sucrase Inhibitory and non-enzymatic glycation properties of Ocimum tenuiflorum L. leaves
by: Antora, R.A., et al.
Published: (2018-05-01)

Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability
by: Xiaoyan Zhou, et al.
Published: (2018-02-01)

Correlation between advanced glycation end-products and the expression of fatty inflammatory factors in type II diabetic cardiomyopathy
by: Zhengdong Guo, et al.
Published: (2015-10-01)

Endothelial Dysfunction in Diabetes Is Aggravated by Glycated Lipoproteins; Novel Molecular Therapies
by: Laura Toma, et al.
Published: (2021-12-01)

The effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes
by: Ekaterina Vladimirovna Ivannikova, et al.
Published: (2014-05-01)